Table: begin end state 1 32 signal peptide 33 44 non-cytoplasmic 45 66 transmembrane 67 72 cytoplasmic 73 92 transmembrane 93 100 non-cytoplasmic 101 123 transmembrane 124 134 cytoplasmic 135 157 transmembrane 158 164 non-cytoplasmic 165 184 transmembrane 185 232 cytoplasmic 233 257 transmembrane 258 270 non-cytoplasmic 271 296 transmembrane 297 303 cytoplasmic 304 324 transmembrane 325 329 non-cytoplasmic 330 354 transmembrane 355 365 cytoplasmic 366 386 transmembrane 387 391 non-cytoplasmic 392 416 transmembrane 417 444 cytoplasmic
Input: >WP_012112845.1 NCBI__GCF_000017645.1:WP_012112845.1 MKTLLLTASLVLLFGILFGFSTASIAGVVEAIAQAFALSTRATEMVVTSLLVGCFIGAAA AAPVSARIGRRPACLLAAVLAMAGYSLIPLGQGVAPGAGMLVAARILIGLGVGLSSMVVP MYAAEVTPARHRGAVVSLFQLAITLGILAGYAVPLALIGRASWQQMLGGGVLVAAACAAI VLLLPESPRWLRSRGMSARADAAARALGISDEMGEEHAPDGANWRAVLGRGATGAVLVLC SVLFVLQNFSGIDGILYYAPHIFTELGFPAGTAALAATFGLGLFNVIATIAAMALVDRLG RRPLLIVGSAAMAVSLGAVIVAALADWPWVALAGLCAYIVAFALSLGPLPYVLMSELFPS AIRERGIAVASATSWLFNGIVAGTFLSVVQGIGLAGTIGIFFVVCVLSLVVSVLFVPETR RIGLEEIEADVLDGRPLRQLGAGG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server